One Genetic Test.
A Lifetime of Health Insights.

One sample

Two initial reports:

  • Proactive Health Report
  • Pharmacogenomics Report

Independent physician review

One-on-one genetic counseling

FSA/HSA eligible

Order Now

Make more informed health decisions throughout life with MyOme Personal Genome™. One sample provides insights into disease and medication response risk informed by your entire genome.

MyOme Personal Genome™







Clinically relevant. Whole genome.

We provide a more complete picture of your disease risk through clinical-grade whole genome sequencing (30x coverage) and analysis–10 times more information than other tests–including rare and common variants and structural alterations.


Genetic information for every stage of your life.

Your genetic testing needs change over time. The MyOme Personal Genome™ platform enables you to receive on-demand health insights at every stage – from family planning to disease-risk information.


Dynamic technology. Actionable findings.

MyOme Personal Genome™ keeps up with the advances and understanding of biology. Our platform utilizes cutting-edge technologies, including machine learning and AI, so you can take advantage of new clinical research findings as they happen.

MyOme Personal Genome™ Reports

A single sample on the MyOme Personal Genome™ platform unlocks a lifetime of health insights.

This report identifies potential mutations in 81 genes known to result in conditions such as cancers, heart disease, metabolic conditions and others. These are deemed actionable findings by the American College of Medical Genetics and Genomics (ACMG).

This report summarizes known variants in 15 genes associated with response to medications that may be used by an independent healthcare provider to optimize your care.

Available Soon: Integrated Personal Risk Score Reports Combining Clinical Factors and Genetics Across Multiple Ancestries

Most genetic tests analyze a panel of single genes that impact only 8% of people1. The MyOme Personal Genome™ risk reports provide risk assessments for everyone. These reports combine an analysis of your genome—not just a panel of genes—coupled with clinical risk factors to provide a personal risk score for a particular condition.

Example of a Coronary Artery Disease (CAD) Integrated Personal Risk Score Report


Heart Health Test that Considers All of You

This report provides a single risk score that integrates genetics with clinical factors to assess risk for coronary artery disease (CAD), for those those who may be missed by clinical evaluation (whereas traditional genetic panels evaluate rare genes impacting a small percent and without assessing CAD risk).

Email Me When Available

MyOme Personal Genome™ members will be automatically notified.

Individualized Breast Cancer Testing for Life

If you have a family history of breast cancer but are negative for single-gene tests, including BRCA1 or BRCA2, you can still be at an elevated risk for breast cancer2. This report provides an integrated risk score that combines genetics with clinical risk factors for women without a known mutation in a breast cancer gene. This test is validated across multiple ancestries3.

Email Me When Available

MyOme Personal Genome™ members will be automatically notified.

Ordering Your MyOme Personal Genome™ Test


Enroll in the MyOme Platform

Submit your order via our secure online portal. A healthcare provider will review and if determined appropriate for you, will order your test.


Send Us Your Sample

Provide your sample right from home in the sample collection kit.


Receive Your Results

Access your first reports in the online portal. Genetic counseling is available.


Stay Updated

Access new reports for a low cost as they are added to the platform to stay informed on advances in clinical research.

Why MyOme Personal Genome™?


Committed to Data Privacy

At MyOme, your data is yours. You can request your DNA data anytime, and we never sell or share your data without your permission. In addition, our platform is HIPAA-compliant and features enterprise-scale data encryption.

Read a personal message from our chief technology officer about our commitment to your privacy and the security of your data.


Genetic Counselors Available

MyOme Personal Genome™ provides complimentary access to genetic counseling to help you understand your results and identify the next steps for your health.

Get More from MyOme Personal Genome™

» Scroll for comparison »
MyOme Personal GenomeOther Genetic Screening Tests4
Whole-genome Based Approach98%
Yes, we sequence over 3,000,000,000 bases
No, they examine or sequence less than 900,000 bases
New ReportsOur whole-genome approach allows for lifelong genetic analyses as research evolvesNo, their data is incomplete
Clinically RelevantYes, our reports focus on clinical risk where there's clear actionabilityLimited clinical utility with a focus on other areas, such as ancestry
Re-interpreted DataYes, because we sequence your genome, your reports can be updated with the latest scientific findingsNo, their data is limited to what they initially examined
Physician ReadyYes, we provide a clinical report signed by a certified laboratory director ready to act onLimitations of how they analyze your genome mean additional testing will likely be required
PrivacyWe will never sell your data without your consent and we abide by industry-leading security protocolsLack of transparency into how they might use your data
Genetic CounselingPost-report genetic counseling is included through our partnersNot always available and often at an additional charge

Frequently Asked Questions

  • Logistical

  • Pharmacogenomics

  • Clinical

  • Reports and Genetic Counseling

  • Costs

Take Action Today

Get ahead of health risks now and for the rest of your life.

Order Now

Stay Updated

Stay informed about the MyOme Personal Genome™ platform.

Get Updates
Rare Diseases Act of 2002.
Shiovitz S, Korde LA. Genetics of breast cancer: a topic in evolution. Ann Oncol. 2015;26: 1291–1299. doi:10.1093/annonc/mdv022
Tshiaba PT, Ratman DK, Sun JM, Tunstall TS, Levy B, Shah PS, et al. Integration of a Cross-Ancestry Polygenic Model With Clinical Risk Factors Improves Breast Cancer Risk Stratification. JCO Precis Oncol. 2023;7: e2200447. doi:10.1200/PO.22.00447
Saey, Tina Hesman. “What Genetic Tests like 23andMe Actually Told Me about My Health.” Science News, 21 Aug. 2019,
In some cases an additional sample might be required.
footer logo

© 2024

MyOme is not responsible for the content or accuracy of third-party websites

The MyOme Personal Genome™ Report was developed, and its performance characteristics were determined, by MyOme, Inc., a clinical laboratory certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high complexity clinical laboratory testing. This test has not been cleared or approved by the U.S. Food and Drug Administration (FDA). College of American Pathologists (CAP) accredited and CLIA certified. ©2024 MyOme, Inc. All Rights Reserved.